NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 203 filers reported holding NEVRO CORP in Q2 2017. The put-call ratio across all filers is 1.52 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $29,730,000 | -5.3% | 372,318 | +2.8% | 0.74% | -3.3% |
| Q1 2018 | $31,400,000 | +7.8% | 362,299 | -14.1% | 0.77% | +12.1% |
| Q4 2017 | $29,128,000 | +5.6% | 421,896 | +39.0% | 0.68% | +3.5% |
| Q3 2017 | $27,578,000 | +13.9% | 303,460 | -6.7% | 0.66% | +9.6% |
| Q2 2017 | $24,215,000 | -16.8% | 325,336 | +4.7% | 0.60% | -18.4% |
| Q1 2017 | $29,090,000 | +24.5% | 310,762 | -3.3% | 0.74% | +22.1% |
| Q4 2016 | $23,359,000 | -14.5% | 321,479 | +22.9% | 0.61% | -14.9% |
| Q3 2016 | $27,311,000 | – | 261,628 | – | 0.71% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 1,446,333 | $82,441,000 | 4.44% |
| Asymmetry Capital Management, L.P. | 31,379 | $1,789,000 | 1.65% |
| TIRSCHWELL & LOEWY INC | 194,470 | $11,085,000 | 1.38% |
| ZEVENBERGEN CAPITAL INVESTMENTS LLC | 673,480 | $38,388,000 | 1.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 525,040 | $29,927,000 | 1.07% |
| Orbimed Advisors | 1,357,691 | $77,388,000 | 0.93% |
| Sio Capital Management, LLC | 45,091 | $2,570,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 60,000 | $3,420,000 | 0.72% |
| SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC | 159,800 | $9,109,000 | 0.62% |
| Endurant Capital Management LP | 24,171 | $1,378,000 | 0.61% |